Literature DB >> 11864715

Psychological heterogeneity in AD/HD--a dual pathway model of behaviour and cognition.

Edmund J S Sonuga-Barke1.   

Abstract

Psychological accounts have characterised attention-deficit/hyperactivity disorder (AD/HD) as either a neuro-cognitive disorder of regulation or a motivational style. Poor inhibitory control is thought to underpin AD/HD children's dysregulation while delay aversion is a dominant characteristic of their motivational style. A recent 'head to head' study of these two accounts suggest that delay aversion and poor inhibitory control are independent co-existing characteristics of AD/HD (combined type). In the present paper we build on these findings to propose a dual pathway model of AD/HD that recognises two quite distinct sub-types of the disorder. In one AD/HD is the result of the dysregulation of action and thought resulting from poor inhibitory control associated with the meso-cortical branch of the dopamine system projecting in the cortical control centres (e.g. pre-frontal cortex). In the other AD/HD is a motivational style characterised by an altered delay of reward gradient linked to the meso-limbic dopamine branch associated with the reward circuits (e.g. nucleus accumbens). The two pathways are further distinguished at the levels of symptoms, cognitive and motivation profiles and genetic and non-genetic origins.

Entities:  

Mesh:

Year:  2002        PMID: 11864715     DOI: 10.1016/s0166-4328(01)00432-6

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  203 in total

1.  Interval length and time-use by children with AD/HD: a comparison of four models.

Authors:  Edmund J S Sonuga-Barke
Journal:  J Abnorm Child Psychol       Date:  2002-06

2.  Exploring deficient emotion regulation in adult ADHD: electrophysiological evidence.

Authors:  Anna Shushakova; Patricia Ohrmann; Anya Pedersen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-02       Impact factor: 5.270

Review 3.  Early pathogenic care and the development of ADHD-like symptoms.

Authors:  Brigitte Dahmen; Vanessa Pütz; Beate Herpertz-Dahlmann; Kerstin Konrad
Journal:  J Neural Transm (Vienna)       Date:  2012-06-02       Impact factor: 3.575

4.  Thalamic alterations in preterm neonates and their relation to ventral striatum disturbances revealed by a combined shape and pose analysis.

Authors:  Yi Lao; Yalin Wang; Jie Shi; Rafael Ceschin; Marvin D Nelson; Ashok Panigrahy; Natasha Leporé
Journal:  Brain Struct Funct       Date:  2014-11-01       Impact factor: 3.270

5.  Does attention-deficit/hyperactivity disorder have a dimensional latent structure? A taxometric analysis.

Authors:  David K Marcus; Tammy D Barry
Journal:  J Abnorm Psychol       Date:  2011-05

Review 6.  Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: current status and working hypotheses.

Authors:  Chandan J Vaidya; Melanie Stollstorff
Journal:  Dev Disabil Res Rev       Date:  2008

7.  Very low frequency EEG oscillations and the resting brain in young adults: a preliminary study of localisation, stability and association with symptoms of inattention.

Authors:  S Helps; C James; S Debener; A Karl; E J S Sonuga-Barke
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

8.  Inhibitory deficits in attention-deficit/hyperactivity disorder are independent of basic processing efficiency and IQ.

Authors:  P Bitsakou; L Psychogiou; M Thompson; E J S Sonuga-Barke
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

9.  Mechanisms of Individual Differences in Impulsive and Risky Choice in Rats.

Authors:  Kimberly Kirkpatrick; Andrew T Marshall; Aaron P Smith
Journal:  Comp Cogn Behav Rev       Date:  2015

10.  Differences in hypothalamic-pituitary-adrenal axis functioning among children with ADHD predominantly inattentive and combined types.

Authors:  Dirk van West; Stephan Claes; Dirk Deboutte
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-03-18       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.